SIERRA IZZO: Open Payments
NPI 1881333722 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,126 in 60 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $759 · 2025 $1,126
Food & beverage: $1,126
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $270 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $261 |
| Janssen Biotech, Inc. | 6 | $106 |
| Regeneron Healthcare Solutions, Inc. | 4 | $73 |
| PFIZER INC. | 4 | $68 |
| Lilly USA, LLC | 2 | $57 |
| Aimmune Therapeutics, Inc. | 2 | $52 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $50 |
| Ipsen Biopharmaceuticals, Inc | 3 | $41 |
| Celltrion USA Inc. | 2 | $41 |
Products named: ENTYVIO, SKYRIZI, TREMFYA, DUPIXENT, RINVOQ, EOHILIA, OMVOH, ZENPEP.
Industry payments across KS — which companies pay providers there.
